Business
Sernova to Present Corporate Update at Canaccord Genuity's 41st Annual Growth Conference
(TheNewswire) L ondon , ON - TheNewswire - ...
About this update from Sernova Biotherapeutics Inc
[{"type":"text","content":"Sernova to Present Corporate Update at Canaccord Genuity's 41st Annual Growth Conference\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n L\n \n \n \n \n ondon\n \n \n \n \n , ON -\n \n \n \n \n TheNewswire\n-\n \n \n \n \n August\n9\n \n \n \n \n ,\n2021\n \n \n \n -\n \n \n Sernova\nCorp\n \n \n .\n \n \n (TSXV:SVA) (FSE/XETRA:PSH) (OTC:SEOVF),\n \n \n a leading clinical-stage company focused on regenerative\nmedicine therapeutics, today announced that Dr. Philip Toleikis,\nPresident and CEO, will provide a corporate update at Canaccord\nGenuity’s 41\n \n \n st\n \n \n Annual Growth Conference on Wednesday,\nAugust 11\n \n \n th\n \n \n , 2021 at 9:30am EDT.\n \n \n \n \n Dr. Toleikis said, “The opportunity to present at\nCanaccord Genuity’s 41\n \n \n st\n \n \n Annual Growth Conference furthers our\nagenda to expand awareness among US investors, institutions, and\nbankers. This presentation will highlight Sernova’s recent clinical\nadvancements and collaborations, and we will share the unprecedented\npotential of our cellular therapeutics platform to transform the\ntreatment and management of chronic diseases, such as diabetes,\nhemophilia, and hypothyroidism. As one example, in our ongoing US\nPhase I/II diabetes clinical trial, our first patient has completed\nthe study protocol and achieved complete insulin independence for over\n15 months (and counting). These interim clinical findings demonstrate\nnot only clinical benefit in a brittle diabetic population but that a\n‘functional cure’ may be achievable for these patients.”\n \n \n \n \n Management will be available throughout the conference\nfor virtual one-on-one meetings. Investors interested in arranging a\nmeeting with the Company’s management during the conference should\ncontact the Canaccord Genuity conference coordinator.\n \n \n \n \n Webcast Link:\n \n \n \n \n A live webcast of Sernova’s presentation session will\nbe available under ‘Featured News’ on the Company’s website\nat\n \n \n \n https://www.sernova.com/press\n \n \n \n \n \n ABOUT\n \n \n SERNOVA\n \n \n \n \n \n \n Sernova is developing regenerative medicine therapeutic technologies\nusing a medical device and immune protected therapeutic cells (i.e.\nhuman donor cells, corrected human cells and stem cell-derived c...